In 1677, a Dutch cloth merchant and self-taught microscopist named Antonie van Leeuwenhoek wrote one of the most awkward letters in the history of science to the Royal Society of London. A medical student named Johan Ham had brought him a semen sample to examine, and Leeuwenhoek, having spotted tiny wriggling "animalcules" inside it, was thrilled — but also worried the topic would strike learned gentlemen as indecent. "If your Lordship should consider that these observations may disgust or scandalise the learned, I earnestly beg your Lordship to regard them as private and to publish or destroy them as your Lordship sees fit," he wrote, visibly on edge. The Society decided to publish anyway. That's how the first-ever description of sperm cells came into being — and, notably, even in that very first observation, Leeuwenhoek already zeroed in on three things: how many "animalcules" were in the sample, how actively they moved, and what shape they had.
Nearly 350 years later, those same three parameters — count, motility, and shape — remain the backbone of every semen analysis. And when all three are impaired at the same time, the result has a name: OAT syndrome, short for oligo-astheno-teratozoospermia. It isn't three separate findings that happen to coincide by chance — it's a consistent clinical pattern in which a man's sperm count, motility, and proportion of normally shaped cells are all reduced simultaneously.
"Oligo" means few, "astheno" means weak, and "terato" — literally "monstrous" in the old medical sense of that Greek root — means abnormally shaped. Oligozoospermia is a reduced concentration of sperm in the ejaculate. Asthenozoospermia is a reduced proportion of actively, progressively moving cells. Teratozoospermia is a reduced proportion of sperm with a normal head, midpiece, and tail structure capable of fertilization.
| Parameter | What it measures | Lower reference limit (WHO, 6th edition, 2021) |
|---|---|---|
| Oligozoospermia | Sperm concentration | 16 million/ml |
| Asthenozoospermia | Sperm motility | 30% progressively motile |
| Teratozoospermia | Sperm morphology (shape) | 4% normal forms by Kruger's strict criteria |
It's worth understanding that these cutoffs aren't a hard line between "fertile" and "infertile" — they're statistical reference points, derived from the distribution of values among men whose partners conceived within a year. A man whose numbers sit slightly below these thresholds can absolutely become a father naturally; statistically, it just tends to take longer.
The path to today's reference values was long, and not always smooth. The World Health Organization released its first semen analysis manual in 1980, and four more editions followed over the next thirty years, with reference values shifting from one edition to the next — sometimes substantially. The fifth edition, published in 2010, lowered the normal thresholds noticeably compared with earlier versions, which set off a wave of debate among fertility specialists: some saw it as a refinement based on better data, others worried it risked telling genuinely struggling patients that their results were "within normal range."
A separate milestone in this history is the work of South African embryologist Thinus Kruger, who in 1986 proposed "strict criteria" for assessing sperm morphology and showed that when the proportion of normal forms fell below 14% — and, in a later study, below 4% — IVF fertilization rates dropped noticeably. Kruger's strict criteria became the foundation of the modern definition of teratozoospermia, and pushed clinics to start taking sperm shape just as seriously as count and motility.
At first glance, it can seem odd that sperm count, motility, and shape so often deteriorate together rather than independently. There's actually solid biology behind it: all three parameters are simply different external signs of the same underlying process — spermatogenesis, the production of sperm inside the seminiferous tubules of the testis. If that process is disrupted, whether by overheating, a hormonal imbalance, oxidative stress, or a genetic cause, every stage of the cell's maturation suffers at once — and so do all three measurable parameters.
OAT is never diagnosed from a single semen analysis: sperm parameters naturally fluctuate from sample to sample depending on a long list of factors, including the period of abstinence, stress, and even the season. The standard is at least two analyses a few weeks apart. If both confirm the picture, a doctor will usually order a hormone panel (testosterone, FSH, LH, prolactin), a scrotal ultrasound to rule out varicocele, and, for severe oligozoospermia (under 5 to 10 million/ml), genetic testing: a karyotype and analysis for Y-chromosome AZF microdeletions.
If a varicocele is found, surgical correction improves semen parameters in some men, though the effect isn't guaranteed and doesn't show up immediately. Lifestyle changes — quitting smoking, losing weight, avoiding overheating — produce a modest but real effect, especially combined with other measures. For most couples dealing with OAT, though, the main practical path forward isn't trying to normalize the semen analysis at all, but assisted reproductive technology — above all ICSI, the method where a single sperm cell is injected directly into an egg, which we covered in detail in the article on surgical sperm retrieval methods. With ICSI, sperm count and motility lose much of their bite: finding just a handful of living cells under the microscope is enough, even if their relative number in the sample is extremely low.
A severe form of OAT, where sperm concentration approaches zero, effectively converges with azoospermia — the state where no sperm at all are found in the ejaculate. In those cases, the diagnostic and treatment logic largely mirrors what we covered in the article on PESA, MESA, TESE, and Micro-TESE: surgically searching for sperm directly within testicular tissue becomes a real consideration.
It's also worth knowing that when genetic testing turns up a hereditary cause — a Y-chromosome microdeletion, for instance — that has a direct bearing on family planning: the trait will be passed on to any sons, and the couple, together with a genetic counselor, will usually discuss not just the current treatment cycle, but the bigger picture, including the possibility of donor sperm down the line if natural conception or ICSI with the man's own sperm turns out not to be an option.
Diagnosing and treating male infertility is a medical rather than a legally regulated field almost everywhere, so access depends mainly on how developed the andrology infrastructure is and how much insurance covers, rather than on legislative restrictions.
| Country | Access to OAT diagnosis and treatment | Notable detail |
|---|---|---|
| United Kingdom | Widely available | The NHS partially covers male infertility diagnostics |
| Spain | Widely available | A well-developed network of andrology labs attached to IVF clinics |
| Germany | Available | Andrology consultations are well integrated into the specialist referral system |
| France | Available | Basic diagnostics are part of the standard infertility work-up |
| Denmark | Available | Strong culture of seeking help early for male-factor issues |
| Portugal | Available | Used alongside IVF/ICSI programmes |
| Czech Republic | Available | Affordable genetic testing for severe oligozoospermia |
| Israel | Widely available | One of the world's leaders in andrology and reproductive genetics |
| Brazil | Available in major cities | A growing market for male reproductive health |
| Greece | Available | Often bundled with sperm donor programmes |
| Cyprus | Available | Growing as part of the medical tourism sector |
| Ukraine | Available | Affordable pricing for semen analysis and extended diagnostics |
The UK and Spain stand out for their well-developed networks of specialist andrology labs, closely integrated with IVF clinics. Israel holds its position as one of the world's centres of expertise in reproductive genetics, which matters particularly when a hereditary cause of OAT is suspected. The Czech Republic and Ukraine offer noticeably more affordable pricing for extended diagnostics — hormone panels and genetic testing — making them appealing destinations for couples who want to balance the quality of their work-up against a reasonable budget.
Nearly three and a half centuries separate Leeuwenhoek's awkward 1677 letter, apologizing for what he considered an indecent topic, from today's routine semen analysis with its precise quantitative criteria. What's curious is that the same three parameters a Dutch cloth merchant with no medical training happened to notice remain the core of male fertility diagnostics to this day — science has simply added exact numbers, microscopes with vastly greater magnification, and an understanding that behind those numbers usually lies a problem that can genuinely be addressed.